2026-07-21T16:08:02Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/176362024-02-08T14:41:55Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927col_20.500.12105_16968col_20.500.12105_16982col_20.500.12105_16984

00925njm 22002777a 4500 dc Pedro-Botet, Juan author Ascaso, Juan F author Barrios, Vivencio author De la Sierra, Alejandro author Escalada, Javier author Millán, Jesús author Mostaza, Jose M author Pérez-Martínez, Pablo author Pintó, Xavier author Salas-Salvadó, Jordi author Valdivielso, Pedro author 2018-10-31 Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. Unfortunately, MetS is typically underrecognized, and there is great heterogeneity in its management, which can hamper clinical decision-making and be a barrier to achieving the therapeutic goals of CVD and diabetes prevention. Although no single treatment for MetS as a whole currently exists, management should be targeted at treating the conditions contributing to it and possibly reversing the risk factors. All this justifies the need to develop recommendations that adapt existing knowledge to clinical practice in our healthcare system. In this regard, professionals from different scientific societies who are involved in the management of the different MetS components reviewed the available scientific evidence focused basically on therapeutic aspects of MetS and developed a consensus document to establish recommendations on therapeutic goals that facilitate their homogenization in clinical decision-making. 10.2147/DMSO.S165740 1178-7007 Diabetes, metabolic syndrome and obesity : targets and therapy http://hdl.handle.net/10668/13220 30464566 http://hdl.handle.net/20.500.12105/17636 Cardiovascular prevention Diabetes prevention Dyslipidemia Hypertension Insulin resistance Obesity COSMIC project: consensus on the objectives of the metabolic syndrome in clinic.